ReviewMedicine international

Clinical outcome of patients with inoperable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus Nab‑paclitaxel as a first‑line therapy: A retrospective analysis.

Hiroyuki Sakaguchi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.